Table 1 - Studies in set up and potentially looking for more sites Please see contacts for more details Phase 3 study in participants with RA (FINCH 3) CCX168 - Avacopan in patients with Vasculitis (ADVOCATE study) The role of the immune system in diseases Condition Study Title Funder/lead Contact Biosimilar A register of investigators/sites Covance If you are interested in becoming Network that would be interested in (commercially funded) a member of this network, conducting Phase 4 clinical follow the link below trials on biosimilars in the future Juvenile-onset BPSU JSLE study- British Paediatric systemic lupus investigating the incidence of Surveillance Unit erythematosus JSLE in patients <18 years in the (BPSU) (JSLE) UK and Ireland Liverpool OA A Study to Determine the Regeneron Efficacy and Safety of Pharmaceuticals Fasinumab for the Treatment of (commercially funded) Adults With Chronic Low Back Pain Osteogenesis Treatment of Osteogenesis University of Edinburgh CI Prof Stuart Ralston Imperfecta Imperfecta with Parathyroid hormone and Zoledronic acid Efficacy and (TOPAZ) Mechanism Evaluation (EME) Program Eli Lilly (Eligibly funded) Polymyositis and Investigating genes in patients Arthritis Research UK, CI Prof WER Ollier dermatomyositis with polymyositis and Myositis Support Group dermatomyositis University of paul.new@liverpool.ac.uk Manchester (Eligibly funded) PsA ScOttish Psoriatic artHritis Glasgow University CI Dr Stefan Seibert Observational Study (SOPHOS) (Eligibly funded) Caron.Paterson@glasgow.ac.uk RA Inhibition of Co-Stimulation in Glasgow University Rheumatoid Arthritis (ICoSRA) (Eligibly funded) RA A randomized, double-blind, EU Stuart.ralston@ed.ac.uk pragmatic (effectiveness and (Eligibly funded) safety) clinical trial on low-dose glucocorticoids (GC) in adult patients with rheumatoid arthritis (RA).
Table 1 - Studies in set up and potentially looking for more sites Please see contacts for more details Phase 3 study in participants with RA (FINCH 3) CCX168 - Avacopan in patients with Vasculitis (ADVOCATE study) The role of the immune system in diseases Condition Study Title Funder/lead Contact Biosimilar Network A register of investigators/sites that would be interested in conducting Phase 4 clinical trials on biosimilars in the future Covance (commercially funded) If you are interested in becoming a member of this network, follow the link below Juvenile-onset systemic lupus erythematosus (JSLE) BPSU JSLE study- investigating the incidence of JSLE in patients <18 years in the UK and Ireland British Paediatric Surveillance Unit (BPSU) Liverpool OA A Study to Determine the Efficacy and Safety of Fasinumab for the Treatment of Adults With Chronic Low Back Pain Regeneron Pharmaceuticals (commercially funded) Osteogenesis Imperfecta Treatment of Osteogenesis Imperfecta with Parathyroid hormone and Zoledronic acid (TOPAZ) University of Edinburgh Efficacy and Mechanism Evaluation (EME) Program Eli Lilly (Eligibly funded) CI Prof Stuart Ralston Polymyositis and dermatomyositis Investigating genes in patients with polymyositis and dermatomyositis Arthritis Research UK, Myositis Support Group University of Manchester (Eligibly funded) CI Prof WER Ollier paul.new@liverpool.ac.uk PsA ScOttish Psoriatic artHritis Observational Study (SOPHOS) Glasgow University (Eligibly funded) CI Dr Stefan Seibert Caron.Paterson@glasgow.ac.uk RA Inhibition of Co-Stimulation in Rheumatoid Arthritis (ICoSRA) Glasgow University (Eligibly funded) RA A randomized, double-blind, pragmatic (effectiveness and safety) clinical trial on low-dose glucocorticoids (GC) in adult patients with rheumatoid arthritis (RA). EU (Eligibly funded) Stuart.ralston@ed.ac.uk